Skip to main content
Fig. 1 | Journal of Medical Case Reports

Fig. 1

From: Atezolizumab in combination with intrathecal chemotherapy and radiation for treatment of isolated cerebral nervous system relapse in a patient with extranodal NK/T cell lymphoma: a case report

Fig. 1

Positron emission tomography-computed tomography (PET-CT) scan at diagnosis of first relapse and after atezolizumab treatment. a Avid left cervical lymphadenopathy and nasopharynx, oropharynx, and soft palate at baseline. b After 16 doses of 1200 mg intravenous infusion of atezolizumab every 3 weeks, showing complete response of the target lesion and overall partial response. c After 24 doses of atezolizumab, the avid region was biopsied and confirmed by pathology to be negative for lymphoma

Back to article page

Journal of Medical Case Reports

ISSN: 1752-1947